News

The patent relates to MonoSol Rx’s Dual Integrated Mixing System. This patented mixing process is designed to provide a continuous batch coating of a drug contained in the

Znomics obtained from Oregon Health & Science University (OHSU), an exclusive biological license to a genetic model of obesity using the zebrafish developed in the OHSU laboratory of

This decision was based upon positive clinical data generated in a 500-subject, Phase I/II study recently completed by Iomai. Guided by data from this study, Iomai will begin

PH-10 is currently undergoing Phase II clinical testing in New York City for the treatment of moderate to severe psoriasis, and Provectus expects to commence Phase II testing

The European Agency for the Evaluation of Medicinal Products (EMEA) established small and medium-sized enterprise (SME) as a dedicated office in 2005 to provide special assistance to small

In the preclinical studies, the combination therapy had an additive effect, inhibiting tumor growth by up to 97% in an irinotecan-resistant mouse xenograft model of colorectal cancer (HT29),

The product will be launched in Germany and Denmark in the coming weeks, followed soon by Ireland, the UK and the rest of EU, and when approved also

This test will enable couples who are planning a pregnancy, or who are already pregnant, to determine if they are carriers and at risk of having a baby

The company expects to present top-line results of this confirmatory Phase III trial by the end of the first half of 2008. The trial is a 400-patient, multi-center,